Verrica Pharmaceuticals Inc [NASDAQ: VRCA] closed the trading session at $0.71 on 2025-07-03. The day’s price range saw the stock hit a low of $0.6474, while the highest price level was $0.7218.
The stocks have a year to date performance of -91.11 percent and weekly performance of 21.32 percent. The stock has been moved at 0.96 percent over the last six months. The stock has performed 33.06 percent around the most recent 30 days and changed 61.20 percent over the most recent 3-months.
If compared to the average trading volume of 420.74K shares, VRCA reached to a volume of 484602 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Verrica Pharmaceuticals Inc [VRCA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VRCA shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VRCA stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Verrica Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 06, 2024. The new note on the price target was released on November 05, 2024, representing the official price target for Verrica Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $10, while Needham analysts kept a Buy rating on VRCA stock.
VRCA stock trade performance evaluation
Verrica Pharmaceuticals Inc [VRCA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 21.32. With this latest performance, VRCA shares gained by 33.06% in over the last four-week period, additionally plugging by 0.96% over the last 6 months – not to mention a rise of 0.96% in the past year of trading.
Verrica Pharmaceuticals Inc [VRCA]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Verrica Pharmaceuticals Inc [VRCA] shares currently have an operating margin of -759.90% and a Gross Margin at 71.60%. Verrica Pharmaceuticals Inc’s Net Margin is presently recorded at -919.21%.
Return on Equity for this stock declined to -121.65%, with Return on Assets sitting at -121.65%.
Earnings per share (EPS) analysis for Verrica Pharmaceuticals Inc [VRCA] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VRCA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Verrica Pharmaceuticals Inc go to 76.18%.
Verrica Pharmaceuticals Inc [VRCA]: Institutional Ownership
There are presently around $31.90%, or 57.34% of VRCA stock, in the hands of institutional investors. The top three institutional holders of VRCA stocks are: PERCEPTIVE ADVISORS LLC with ownership of 7.1 million shares, which is approximately 15.2663%. AVORO CAPITAL ADVISORS LLC, holding 4.0 million shares of the stock with an approximate value of $$29.16 million in VRCA stocks shares; and AVORO CAPITAL ADVISORS LLC, currently with $$9.25 million in VRCA stock with ownership which is approximately 2.7299%.
